Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment

SUMMARY: Gonadotropin-releasing hormone (GnRH) agonists, currently used in the treatment of advanced prostate cancer, have been described as a rare cause of pituitary apoplexy, a potentially life-threatening clinical condition. We report the case of a 69-year-old man with a known pituitary macroaden...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbosa, Mariana, Paredes, Sílvia, Machado, Maria João, Almeida, Rui, Marques, Olinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Unusual Effects of Medical Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354737/
https://www.ncbi.nlm.nih.gov/pubmed/32554827
http://dx.doi.org/10.1530/EDM-20-0018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354737/
https://www.ncbi.nlm.nih.gov/pubmed/32554827
http://dx.doi.org/10.1530/EDM-20-0018

Ejemplares similares